Receptor-dependent and receptor-independent endocannabinoid signaling: A therapeutic target for regulation of cancer growth

Life Sciences

Volumn 92, Issue 8-9, 2013, Pages 463-466

  Van Dross, Rukiyah ^a   Soliman, Eman ^a   Jha, Shalini ^b   Johnson, Travious ^b   Mukhopadhyay, Somnath ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

Cancer; Cannabinoids; Endocannabinoids; Receptor dependent; Receptor independent; Tumor cells

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACYLGLYCEROL LIPASE; ANANDAMIDE; ARVANIL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 2; FATTY ACID AMIDASE; METHANANDAMIDE; N OLEOYLETHANOLAMINE; OLEAMIDE; RIMONABANT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CONFERENCE PAPER; DRUG POTENTIATION; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; PROSTATE CANCER;

AMIDOHYDROLASES; ANIMALS; ANTINEOPLASTIC AGENTS; CYCLOOXYGENASE 2; ENDOCANNABINOIDS; HUMANS; MEMBRANE MICRODOMAINS; MONOACYLGLYCEROL LIPASES; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 84874658451     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.09.025     Document Type: Conference Paper

References (35)

1. M. Bari, N. Battista, F. Fezza, A. Finazzi-Agro, and M. Maccarrone Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis J Biol Chem 280 2005 12212 12220
2. T. Bisogno, K. Katayama, D. Melck, N. Ueda, L. De Petrocellis, and S. Yamamoto Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells - implications for cell proliferation and differentiation Eur J Biochem 254 1998 634 642 (Pubitemid 28308116)
3. M.M. Caffarel, C. Andradas, E. Mira, E. Pérez-Gómez, C. Cerutti, and G. Moreno-Bueno Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition Mol Cancer 9 2010 196 206
4. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87 (Pubitemid 26374593)
5. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, and B.R. Martin Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc Natl Acad Sci U S A 98 2001 9371 9376 (Pubitemid 32743923)
6. S. DeMorrow, S. Glaser, H. Francis, J. Venter, B. Vaculin, and Vaculin Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts J Biol Chem 282 2007 13098 13113 (Pubitemid 47100640)
7. L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, and V. DiMarzo The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Proc Natl Acad Sci U S A 95 837 1998 5 80
8. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, and G. Tarzia Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 2005 352 358 (Pubitemid 40411361)
9. J. Guindon, and A.G. Hohmann The endocannabinoid system and cancer: therapeutic implication Br J Pharmacol 163 2011 1447 1463
10. L. Hamtiaux, L. Hansoulle, N. Dauguet, G.G. Muccioli, B. Gallez, and D.M. Lambert Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism PLoS One 6 2011 e26823
11. D.J. Hermanson, and L.J. Marnett Cannabinoids, endocannabinoids, and cancer Cancer Metastasis Rev 30 2011 599 612
12. S. Jin, F. Zhou, F. Katirai, and P.L. Li Lipid raft redox signaling: molecular mechanisms in health and disease Antioxid Redox Signal 15 2011 1043 1083
13. K.R. Kozak, B.C. Crews, J.D. Morrow, L.H. Wang, Y.H. Ma, and R. Weinander Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J Biol Chem 277 2002 44877 44885 (Pubitemid 36159083)
14. C. Kuc, A. Jenkins, and R.T. Van Dross Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade Mol Carcinog 51 2012 139 149
15. I. Matias, J. Chen, P.L. De, T. Bisogno, A. Ligresti, and F. Fezza Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism J Pharmacol Exp Ther 309 2004 745 757 (Pubitemid 38542631)
16. S.D. McAllister, R.T. Christian, M.P. Horowitz, A. Garcia, and P.Y. Desprez Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells Mol Cancer Ther 6 2007 2921 2927 (Pubitemid 350206770)
17. D. Melck, D. Rueda, I. Galve-Roperh, L. De Petrocellis, M. Guzmán, and V. Di Marzo Involvement of the cAMP/protein kinase A pathway and of mitogen-activated proteinkinase in the anti-proliferative effects of anandamide in human breast cancer cells FEBS Lett. 463 1999 235 240 (Pubitemid 30001925)
18. D. Melck, L. De Petrocellis, P. Orlando, T. Bisogno, C. Laezza, and M. Bifulco Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation Endocrinology 2000 141 2000 118 126 (Pubitemid 32260350)
19. M. Mimeault, N. Pommery, N. Wattez, C. Bailly, and J.P. Hénichart Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production Prostate 56 2003 1 12 (Pubitemid 36613150)
20. D.K. Nomura, J.Z. Long, S. Niessen, H.S. Hoover, S.W. Ng, and B.F. Cravatt Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis Cell 140 2010 49 61
21. D.K. Nomura, D.P. Lombardi, J.W. Chang, S. Niessen, A.M. Ward, and J.Z. Long Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer Chem Biol 18 2011 846 856
22. N. Olea-Herrero, D. Vara, S. Malagarie-Cazenave, and I. Diaz-Laviada Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-methanandamide and JWH-015: involvement of CB2 Br J Cancer 101 2009 940 950
23. H.A. Patsos, D.J. Hicks, R.R. Dobson, A. Greenhough, N. Woodman, and J.D. Lane The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 Gut 54 2005 1741 1750 (Pubitemid 41697674)
24. H.A. Patsos, A. Greenhough, D.J. Hicks, K.M. Al, T.J. Collard, and J.D. Lane The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells Int J Oncol 37 2010 187 193
25. Z. Qamri, A. Preet, M.W. Nasser, C.E. Bass, G. Leone, and S.H. Barsky Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer Mol Cancer Ther 8 2009 3117 3129
26. R. Ramer, K. Brune, A. Pahl, and B. Hinz R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism Biochem Biophys Res Commun 286 2001 1144 1152 (Pubitemid 32924889)
27. S.M. Saario, and J.T. Laitinen Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors Basic Clin Pharmacol Toxicol 101 2007 287 293 (Pubitemid 47512389)
28. S. Sarfaraz, F. Afaq, V.M. Adhami, and H. Mukhtar Cannabinoid receptor as a novel target for the treatment of prostate cancer Cancer Res 65 2005 1635 1641 (Pubitemid 40478586)
29. S. Sarfaraz, F. Afaq, V.M. Adhami, A. Malik, and H. Mukhtar Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest J Biol Chem 281 2006 39480 39491 (Pubitemid 46041908)
30. K.P. Sarker, and I. Maruyama Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts Cell Mol Life Sci 60 2003 1200 1208 (Pubitemid 36791921)
31. D. Sarnataro, S. Pisanti, A. Santoro, P. Gazzerro, A.M. Malfitano, and C. Laezza The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism Mol Pharmacol 70 2006 1298 1306 (Pubitemid 44435982)
32. M.R. Scuderi, G. Cantarella, M. Scollo, L. Lempereur, M. Palumbo, and G. Saccani-Jotti The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft Cancer Lett 310 2011 240 249
33. L. Thors, A. Bergh, E. Persson, P. Hammarsten, P. Stattin, and L. Egevad Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4 PLoS One 5 2010 e12275
34. R.T. Van Dross Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes Mol Carcinog 48 2009 724 732
35. M. Yu, D. Ives, and C.S. Ramesha Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2 J Biol Chem 272 1997 21181 21186 (Pubitemid 27373979)